Americans Will Spend Half Their Lives Taking Prescription Drugs, Study Finds
October 20, 2023
Rand Paul Says Wuhan Lab COVID-19 Connections & Coverup Will ‘Bring Down Anthony Fauci’
October 20, 2023

Gates Foundation Funding $40 Million Effort to Develop mRNA Vaccines in Africa

Bill Gates


A $40 million investment will help several African manufacturers produce new mRNA vaccines on the continent, the Bill & Melinda Gates Foundation has announced.

[Image source: Wikimedia]


The Bill & Melinda Gates Foundation has been working increasingly closely with the pharma industry in recent years. During the COVID-19 pandemic it invested heavily in multinational drug and vaccine companies, profiting massively as mandates and mainstream media propaganda conspired to pressure billions of people into getting vaccinated. But while the African continent has thus far largely avoided employing the experimental shots, Gates now seems intent on changing this. He won’t find it easy, however, as the developmental timeline for rolling out mRNA vaccines in Africa has been estimated to be anywhere from three to seven years.

What Gates’ new African pharma investment makes clear, of course, is that his personal strategies for developing and distributing COVID-19 vaccines are rapidly becoming the world’s strategies. This is because global institutions such as the World Health Organization (WHO) have essentially ceded their leadership to a group of public-private partnerships that are themselves massively funded by Gates. These organizations, which include the Coalition for Epidemic Preparedness Innovations and GAVI, the Vaccine Alliance, are working with the WHO to develop what they say is “the largest and most diverse Covid-19 vaccine portfolio in the world.” Having taken such significant sums of money from Gates, it is unthinkable that these bodies would employ any strategies perceived by him to be contrary to his interests.

To read how, in recent years, the Bill and Melinda Gates Foundation has become the second largest funder of the WHO, see this article on our website.